These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 16770250

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome.
    Fagioli F, Biasin E, Berger M, Nesi F, Saroglia EH, Miniero R, Martino S, Tovo PA.
    Bone Marrow Transplant; 2003 Jan; 31(2):133-6. PubMed ID: 12621496
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE.
    N Engl J Med; 1999 Feb 18; 340(7):508-16. PubMed ID: 10021471
    [Abstract] [Full Text] [Related]

  • 5. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH, Lee JH, Lee JH, Kim DY, Kim SH, Shin HJ, Lee YS, Kang YA, Seol M, Ryu SG.
    Biol Blood Marrow Transplant; 2009 Jan 18; 15(1):61-72. PubMed ID: 19135944
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A, Olivé T, Martinez A, Bureo E, Maldonado MS, Diaz de Heredia C, Sastre A, Gonzalez-Vicent M, Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Pediatr Hematol Oncol; 2007 Sep 18; 24(6):393-402. PubMed ID: 17710656
    [Abstract] [Full Text] [Related]

  • 7. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

  • 8. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct 15; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 9. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Oct 15; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 10. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F, Raffoux C, Griscelli C, Fischer A.
    J Immunol; 1987 Jan 15; 138(2):423-7. PubMed ID: 3540121
    [Abstract] [Full Text] [Related]

  • 11. Umbilical cord blood transplantation--how, when and for whom?
    Cohen Y, Nagler A.
    Blood Rev; 2004 Sep 15; 18(3):167-79. PubMed ID: 15183901
    [Abstract] [Full Text] [Related]

  • 12. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies.
    Díaz de Heredia C, Ortega JJ, Díaz MA, Olivé T, Badell I, González-Vicent M, Sánchez de Toledo J.
    Bone Marrow Transplant; 2008 Apr 15; 41(7):627-33. PubMed ID: 18084339
    [Abstract] [Full Text] [Related]

  • 13. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
    Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R.
    Biol Blood Marrow Transplant; 2005 May 15; 11(5):349-53. PubMed ID: 15846288
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow transplantation without conditioning regimen in Omenn syndrome: a case report.
    Mellouli F, Torjmen L, Ksouri H, Abdelkefi A, Ladab S, Barbouche R, Othman TB, Hassen AB, Bejaoui M.
    Pediatr Transplant; 2007 Dec 15; 11(8):922-6. PubMed ID: 17976129
    [Abstract] [Full Text] [Related]

  • 15. Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell-depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts.
    Meijer E, Bloem AC, Dekker AW, Verdonck LF.
    Transplantation; 2003 Jun 15; 75(11):1910-3. PubMed ID: 12811256
    [Abstract] [Full Text] [Related]

  • 16. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B, Trakhtenbrot L, Amariglio N, Rothman R, Tabori U, Dallal I, Golan H, Neumann Y, Reichart M, Kaplinsky C, Rechavi G, Toren A.
    Bone Marrow Transplant; 2004 Aug 15; 34(4):317-20. PubMed ID: 15220954
    [Abstract] [Full Text] [Related]

  • 17. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J, Herber M, Schwamberger S, Panzer W, Adler H, Kolb HJ.
    Exp Hematol; 2009 Aug 15; 37(8):998-1006. PubMed ID: 19446000
    [Abstract] [Full Text] [Related]

  • 18. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
    Boelens JJ, Rocha V, Aldenhoven M, Wynn R, O'Meara A, Michel G, Ionescu I, Parikh S, Prasad VK, Szabolcs P, Escolar M, Gluckman E, Cavazzana-Calvo M, Kurtzberg J, EUROCORD, Inborn error Working Party of EBMT and Duke University.
    Biol Blood Marrow Transplant; 2009 May 15; 15(5):618-25. PubMed ID: 19361754
    [Abstract] [Full Text] [Related]

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 20. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.